(Q45289864)

11 December 2017

title

Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation (English)

1 reference

11 December 2017

1 reference

Stephan R Lederer

1

1 reference

11 December 2017

Nicole Friedrich

2

1 reference

11 December 2017

Bernhard Banas

3

1 reference

11 December 2017

Georg Welser

4

1 reference

11 December 2017

Ekkehard D Albert

5

1 reference

11 December 2017

Thomas Sitter

6

1 reference

11 December 2017

publication date

1 April 2005

1 reference

11 December 2017

published in

Clinical Transplantation

1 reference

11 December 2017

volume

19

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

168-174

1 reference

Immunosuppressive drugs: the first 50 years and a glance forward

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Anti-HLA antibodies after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

The use of mycophenolate mofetil in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Use of mycophenolate mofetil as rescue therapy after pediatric liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Hospitalizations for cytomegalovirus disease after renal transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

High Survival Rates of Kidney Transplants from Spousal and Living Unrelated Donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00261.X

10.1111/J.1399-0012.2005.00261.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference